Related Experiment Videos
Diode laser cyclophotocoagulation in refractory glaucoma
M C Linsen1, C Mannes, T Zeyen
1Department of Ophthalmology, Middelheim Hospital, Antwerp, Belgium.
Bulletin De La Societe Belge D'Ophtalmologie
|January 27, 1999
Summary
Contact diode cyclophotocoagulation effectively lowers intraocular pressure (IOP) and reduces medication needs in patients with intractable glaucoma. This safe procedure offers a viable treatment option for refractory glaucoma cases.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Interventions
Background:
- Intractable glaucoma poses significant challenges to maintaining ocular health.
- Refractory glaucoma often requires advanced treatment modalities.
- Contact diode cyclophotocoagulation is an established, though sometimes debated, therapeutic option.
Purpose of the Study:
- To evaluate the efficacy and safety of contact diode cyclophotocoagulation.
- To assess the impact of the procedure on intraocular pressure (IOP).
- To determine changes in the number of glaucoma medications post-treatment.
Main Methods:
- Retrospective analysis of 19 eyes from 19 patients with intractable glaucoma.
- Treatment involved contact diode cyclophotocoagulation.
- Intraocular pressure (IOP) and medication usage were monitored pre- and post-procedure.
Main Results:
- Mean IOP significantly decreased from 31.7 mmHg to 23.7 mmHg (p=0.02).
- The average number of glaucoma medications required fell from 1.9 to 1.3 (p=0.03).
- Mean follow-up duration was 4 months, ranging from 1 to 11 months.
Conclusions:
- Contact diode cyclophotocoagulation demonstrates effectiveness in managing refractory glaucoma.
- The procedure is associated with significant reductions in IOP and medication burden.
- Diode cyclophotocoagulation appears to be a safe and beneficial option for intractable glaucoma.